DocGo Inc. (DCGO) stock
Close on Nov 13, 2026Market cap $20.54MP/E –Yield –
Earnings
DocGo's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of DocGo's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 15, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 9, 2026after the close | $73.40M | +3.7% | -$0.17 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 17, 2026after the close | $73.40M | -8.7% | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026after the close | $75.60M | -21.3% | -$0.15 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 16, 2026after the close | $74.90M | -38.0% | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 10, 2025after the close | $70.80M | -49.0% | -$0.28 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025after the close | $80.40M | -51.2% | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025after the close | $96.00M | -50.0% | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025after the close | $120.80M | -39.4% | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024after the close | $138.70M | -25.7% | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $164.90M | +31.4% | $0.06 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024after the close | $192.10M | +70.0% | $0.10 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024after the close | $199.20M | +83.1% | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 6, 2023after the close | $186.60M | +78.9% | $0.05 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023after the close | $125.50M | +14.6% | -$0.02 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023after the close | $113.00M | -4.2% | -$0.03 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 13, 2023after the close | $108.80M | -10.3% | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022after the close | $104.30M | +21.5% | $0.03 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022after the close | $109.50M | – | $0.11 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022after the close | $117.90M | – | $0.09 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 14, 2022after the close | $121.30M | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | $85.84M | – | $27.03 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
DocGo's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| base business revenue increase | FY2026 | +12% – +20% | – | New | Nov 10, 2025 |
| revenue | FY2026 | $300.00M | – | New | Nov 9, 2026 |
| revenue | FY2026 | $305.00M – $310.00M | $300.00M – $315.00M | Narrowed | Aug 17, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | -$22.00M – -$17.00M | – | New | Nov 9, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | -$22.00M – -$17.00M | -$10.00M – -$5.00M | Lowered | Aug 17, 2026 |
Guidance vs results
The last range DocGo gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $315.00M – $320.00M | $322.10MΣ4Q | Above range |
Guidance history
Every forecast DocGo put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 9, 2026 | adjusted EBITDA | FY2026 | -$22.00M – -$17.00M | New |
| Nov 9, 2026 | revenue | FY2026 | $300.00M | New |
| Aug 17, 2026 | adjusted EBITDA | FY2026 | -$22.00M – -$17.00M | Lowered |
| Aug 17, 2026 | revenue | FY2026 | $305.00M – $310.00M | Narrowed |
| May 11, 2026 | adjusted EBITDA | FY2026 | -$10.00M – -$5.00M | Reaffirmed |
| May 11, 2026 | revenue | FY2026 | $300.00M – $315.00M | Raised |
| Mar 16, 2026 | adjusted EBITDA | FY2026 | -$10.00M – -$5.00M | Raised |
| Mar 16, 2026 | revenue | FY2026 | $290.00M – $310.00M | Raised |
| Nov 10, 2025 | adjusted EBITDA | FY2025 | -$28.00M – -$25.00M | New |
| Nov 10, 2025 | adjusted EBITDA | FY2026 | -$25.00M – -$15.00M | New |
| Nov 10, 2025 | revenue | FY2025 | $315.00M – $320.00M | New |
| Nov 10, 2025 | base business revenue increase | FY2026 | +12% – +20% | New |
| Nov 10, 2025 | revenue | FY2026 | $280.00M – $300.00M | New |
| Aug 7, 2025 | adjusted EBITDA | FY2025 | -$30.00M – -$20.00M | Reaffirmed |
| Aug 7, 2025 | revenue | FY2025 | $300.00M – $330.00M | Reaffirmed |
| May 8, 2025 | adjusted EBITDA | FY2025 | -$30.00M – -$20.00M | New |
| May 8, 2025 | revenue | FY2025 | $300.00M – $330.00M | Lowered |
| Feb 27, 2025 | adjusted EBITDA margin | FY2025 | 5% | Lowered |
| Feb 27, 2025 | revenue | FY2025 | $410.00M – $450.00M | Reaffirmed |
| Nov 7, 2024 | adjusted EBITDA | FY2024 | $70.00M – $75.00M | Raised |
| Nov 7, 2024 | cash flow from operations | FY2024 | $90.00M – $100.00M | Raised |
| Nov 7, 2024 | adjusted EBITDA margin | FY2025 | 8% – 10% | Lowered |
| Nov 7, 2024 | revenue guidance | FY2024 | $620.00M – $630.00M | Narrowed |
| Nov 7, 2024 | revenue | FY2025 | $410.00M – $450.00M | New |
| Aug 7, 2024 | adjusted EBITDA | FY2024 | $65.00M – $75.00M | Reaffirmed |
| Aug 7, 2024 | Revenue for our 2024 base business | FY2024 | $280.00M – $300.00M | Raised |
| Aug 7, 2024 | cash flow from operations | FY2024 | $80.00M – $90.00M | Lowered |
| Aug 7, 2024 | adjusted EBITDA margin | FY2025 | 10% | New |
| Aug 7, 2024 | base business | FY2025 | +30% | New |
| Aug 7, 2024 | revenue | FY2024 | $600.00M – $650.00M | Reaffirmed |
| May 8, 2024 | adjusted EBITDA | FY2024 | $65.00M – $75.00M | Lowered |
| May 8, 2024 | cash flow from operations | FY2024 | $70.00M – $80.00M | Raised |
| May 8, 2024 | revenue guidance | FY2024 | $600.00M – $650.00M | Lowered |
| Feb 28, 2024 | adjusted EBITDA | FY2024 | $80.00M – $85.00M | New |
| Feb 28, 2024 | cash flow from operations | FY2024 | $65.00M – $75.00M | New |
| Feb 28, 2024 | revenues | FY2024 | $720.00M – $750.00M | New |
| Nov 6, 2023 | adjusted EBITDA | FY2023 | $50.00M – $55.00M | Raised |
| Nov 6, 2023 | revenue | FY2023 | $615.00M – $625.00M | Raised |
| Aug 7, 2023 | Adjusted EBITDA | FY2023 | $48.00M – $53.00M | Raised |
| Aug 7, 2023 | gross margin exit rate | FY2023 | 37% | Raised |
| Aug 7, 2023 | remote patient and device monitoring patients | FY2023 | 50,000 | New |
| Aug 7, 2023 | revenue | FY2023 | $540.00M – $550.00M | Raised |
| May 8, 2023 | Adjusted EBITDA | FY2023 | $45.00M – $50.00M | Reaffirmed |
| May 8, 2023 | gross margin | FY2023 | 35% | New |
| May 8, 2023 | revenue | FY2023 | $500.00M – $510.00M | New |
| Mar 13, 2023 | Adjusted EBITDA | FY2023 | $45.00M – $50.00M | New |
| Mar 13, 2023 | gross margin | FY2023 | 35% | New |
| Mar 13, 2023 | revenue | FY2023 | $500.00M – $510.00M | New |
| Nov 7, 2022 | Adjusted EBITDA | FY2022 | $41.00M – $46.00M | Raised |
| Nov 7, 2022 | Revenue | FY2022 | $430.00M – $440.00M | Raised |
| Aug 8, 2022 | Adjusted EBITDA | FY2022 | $40.00M – $45.00M | Raised |
| Aug 8, 2022 | Revenue guidance | FY2022 | $425.00M – $435.00M | Raised |
| May 10, 2022 | Adjusted EBITDA | FY2022 | $35.00M – $41.00M | Reaffirmed |
| May 10, 2022 | revenue | FY2022 | $400.00M – $420.00M | Reaffirmed |
| Mar 14, 2022 | Adjusted EBITDA | FY2022 | $35.00M – $41.00M | New |
| Mar 14, 2022 | revenue | FY2022 | $400.00M – $420.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases DocGo filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
See a number that looks wrong?